2508 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2024
JOURNALCancer science
PREMIER AUTEURChavanton A
TITRELAG-3 : recent developments in combinational therapies in cancer.
ANNÉE2024
JOURNALJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
PREMIER AUTEURLigurgo O
TITREAcute pancreatitis and large cystic pancreatic tumor in an adolescent.
ANNÉE2024
JOURNALCell death & disease
PREMIER AUTEURGiolito MV
TITREImpact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
ANNÉE2024
JOURNALCancer medicine
PREMIER AUTEURPetit T
TITRETrastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
ANNÉE2024
JOURNALSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
PREMIER AUTEURDamerval M
TITREAttributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations.
ANNÉE2024
JOURNALRespiratory medicine and research
PREMIER AUTEURMoro-Sibilot D
TITREStudy design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer.
ANNÉE2024
JOURNALEuropean journal of nuclear medicine and molecular imaging
PREMIER AUTEURPepponi M
TITRE[Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.
ANNÉE2024
JOURNALTherapeutic advances in medical oncology
PREMIER AUTEURSterlé M
TITREImproving olaparib exposure to optimize adverse effects management.
ANNÉE2024
JOURNALAnnales pharmaceutiques francaises
PREMIER AUTEURSterlé M
TITREThe harms of inappropriate digoxin prescribing in cancer patients : a drug-drug interaction with posaconazole.
ANNÉE2024
JOURNALSeminars in liver disease
PREMIER AUTEURSaviano A
TITRETight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques